GABAPENTIN | A206943 | STRIDES PHARMA GLOBAL PTE LTD
Highest NADAC/Unit
$0.0410
per ea
Lowest NADAC/Unit
$0.0210
per ea
Brand NDCs
0
Generic NDCs
12
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 64380073102GABAPENTIN 400 MG CAPSULE | $0.0410 | EA | Generic | — | 2026-06-17 |
| 64380073101GABAPENTIN 400 MG CAPSULE | $0.0410 | EA | Generic | — | 2026-06-17 |
| 71093012204GABAPENTIN 400 MG CAPSULE | $0.0410 | EA | Generic | — | 2026-06-17 |
| 71093012205GABAPENTIN 400 MG CAPSULE | $0.0410 | EA | Generic | — | 2026-06-17 |
| 64380075402GABAPENTIN 300 MG CAPSULE | $0.0324 | EA | Generic | — | 2026-06-17 |
| 71093012105GABAPENTIN 300 MG CAPSULE | $0.0324 | EA | Generic | — | 2026-06-17 |
Showing 6 of 12 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.